Prevalence of Cardiovascular Disease Risk Factors and NT pro-BNP for Cardiovascular Disease Risk Prediction among Older People Living with HIV in Almaty, Kazakhstan
Related Experiment Video
Updated: Apr 28, 2026
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Nursultan Nurzhigitov1, Deborah Gustafson2, Zhamilya Nugmanova1
1SPH, Kazakh National Medical University (KNMU).
Insights
More than half of older people living with HIV in Kazakhstan face moderate to high cardiovascular disease risk, driven by traditional factors. Routine risk assessment and prevention are crucial for integrated HIV care.
Area of Science:
- Public Health
- Cardiology
- Infectious Diseases
Background:
- Cardiovascular disease (CVD) is a leading cause of premature death in Kazakhstan and the region.
- Increasing life expectancy for people living with HIV (PLWH) on antiretroviral therapy (ART) highlights CVD risk as a major clinical concern.
- Limited data exists on CVD risk and cardiac biomarkers in older PLWH in Kazakhstan.
Purpose of the Study:
- To estimate CVD risk factor prevalence in Almaty-based PLWH aged ≥40.
- To assess 10-year CVD risk using SCORE2/SCORE2-OP models.
- To evaluate the role of NT-proBNP in this population.
Main Methods:
- A cross-sectional study of 150 PLWH (≥40 years) in Almaty.
- Data collection included sociodemographic, behavioral, clinical, and laboratory parameters.
- 10-year CVD risk calculated via SCORE2/SCORE2-OP; multivariable logistic regression identified NT-proBNP predictors.
Main Results:
- The cohort (mean age 51.6 years) had high ART coverage (95%) and viral suppression (76.7%).
- High prevalence of smoking (76.1%) and alcohol use (65.5%) was observed.
- 54% had moderate or high 10-year CVD risk; 36.3% had elevated NT-proBNP, independently associated with older age.
Conclusions:
- Over half of older PLWH in this cohort exhibit moderate to high predicted 10-year CVD risk, despite high ART coverage.
- Traditional cardiovascular risk factors are the primary drivers of this elevated risk.
- Urgent integration of routine CVD risk assessment and targeted prevention strategies into HIV care is recommended.
Introduction:
Cardiovascular disease (CVD) is the leading cause of premature mortality in Kazakhstan and across Eastern Europe and Central Asia. As life expectancy increases among people living with HIV (PLWH) receiving antiretroviral therapy (ART), cardiovascular risk has become a major clinical concern. However, data on CVD risk distribution and cardiac biomarkers among older PLWH in Kazakhstan remain limited. This study aimed to estimate the prevalence of CVD risk factors, assess 10-year CVD risk using SCORE2/SCORE2-OP, and evaluate the role of NT-proBNP among PLWH aged ≥ 40 years in Almaty.
Methods:
A cross-sectional study was conducted among 150 PLWH aged ≥ 40 years attending the Almaty City AIDS Center between February and July 2023. Sociodemographic, behavioral, clinical, and laboratory data were collected. Ten-year CVD risk was calculated using SCORE2 (ages 40-69 years) and SCORE2-OP (≥ 70 years). Multivariable logistic regression was used to identify predictors of elevated NT-proBNP (≥ 125 pg/mL).
Results:
The mean age was 51.6 ± 10.4 years, and 54.7% of participants were male. ART coverage was 95%, with 76.7% achieving viral suppression. Smoking (76.1%) and alcohol use (65.5%) were highly prevalent. Overall, 29.3% of participants had low, 40.7% moderate, and 30.0% high 10-year CVD risk; 54% were classified as moderate or high risk. Elevated NT-proBNP (≥ 125 pg/mL) was observed in 36.3% of participants. In multivariable analysis, older age was independently associated with elevated NT-proBNP (adjusted odds ratio [aOR] per 1-year increase: 1.10; 95% CI: 1.04-1.15; p = 0.0004), whereas HIV viral load, blood pressure, sex, and triglyceride levels were not independently associated.
Conclusions:
More than half of older PLWH in this urban Kazakhstan cohort had moderate or high predicted 10-year CVD risk despite high ART coverage. Traditional cardiovascular risk factors were the primary drivers. Integration of routine CVD risk assessment and targeted prevention strategies into HIV care is urgently needed.
More Related Videos
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:26Coronary Artery Disease IV: Preventive Measures
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:30Coronary Artery Disease I: Introduction
01:30Coronary Artery Disease III: Clinical Manifestations
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies